People | March 17, 2022
Flipkart Health+ appoints Prashant Jhaveri as CEO
Prashant comes with over 17 years of experience in the health, health insurance and other allied healthcare sectors
Prashant comes with over 17 years of experience in the health, health insurance and other allied healthcare sectors
Scientists worldwide have started employing wastewater analysis as an efficient and cost-effective approach for assessing the dynamics of the virus in a population. Several scientific methods are being developed to rapidly decode the message carried by sewage
The Prescription Drug User Fee Action (PDUFA) date for adagrasib is December 14, 2022
Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics
Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
Application based on DESTINY-Breast03 results showing Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan reduced risk of disease progression or death by 72% versus trastuzumab emtansine (T-DM1)
He has over 22 years of experience in pharmaceutical sales & business development
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
The surgery was helmed by Prof. Dr. Vishwanath Pai, Sr. Consultant, Department of Minimally Invasive Surgery, Prashanth Hospitals, Velachery
Subscribe To Our Newsletter & Stay Updated
